A detailed history of Avestar Capital, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Avestar Capital, LLC holds 2,945 shares of ZTS stock, worth $480,947. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,945
Previous 2,559 15.08%
Holding current value
$480,947
Previous $443,000 29.8%
% of portfolio
0.06%
Previous 0.05%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$172.58 - $196.48 $66,615 - $75,841
386 Added 15.08%
2,945 $575,000
Q2 2024

Aug 08, 2024

BUY
$145.54 - $178.83 $61,708 - $75,823
424 Added 19.86%
2,559 $443,000
Q1 2024

May 10, 2024

BUY
$165.67 - $199.94 $18,058 - $21,793
109 Added 5.38%
2,135 $361,000
Q4 2023

Feb 12, 2024

BUY
$151.44 - $200.09 $39,374 - $52,023
260 Added 14.72%
2,026 $399,000
Q3 2023

Oct 20, 2023

SELL
$167.14 - $192.77 $7,521 - $8,674
-45 Reduced 2.48%
1,766 $307,000
Q2 2023

Aug 01, 2023

BUY
$160.94 - $186.23 $24,301 - $28,120
151 Added 9.1%
1,811 $311,000
Q1 2023

Apr 20, 2023

BUY
$145.48 - $175.02 $241,496 - $290,533
1,660 New
1,660 $276,000
Q3 2022

Oct 26, 2022

SELL
$148.29 - $182.55 $94,460 - $116,284
-637 Reduced 31.75%
1,369 $203,000
Q2 2022

Jul 28, 2022

SELL
$155.97 - $200.09 $36,964 - $47,421
-237 Reduced 10.57%
2,006 $345,000
Q1 2022

Apr 26, 2022

BUY
$181.39 - $234.03 $21,404 - $27,615
118 Added 5.55%
2,243 $423,000
Q4 2021

Feb 01, 2022

BUY
$193.69 - $247.03 $60,624 - $77,320
313 Added 17.27%
2,125 $519,000
Q3 2021

Nov 09, 2021

BUY
$189.29 - $209.69 $17,225 - $19,081
91 Added 5.29%
1,812 $352,000
Q2 2021

Aug 03, 2021

BUY
$155.9 - $187.99 $5,144 - $6,203
33 Added 1.95%
1,721 $321,000
Q1 2021

May 03, 2021

BUY
$144.0 - $169.39 $23,040 - $27,102
160 Added 10.47%
1,688 $290,000
Q4 2020

Feb 01, 2021

SELL
$157.07 - $174.35 $1,884 - $2,092
-12 Reduced 0.78%
1,528 $253,000
Q3 2020

Oct 29, 2020

SELL
$137.1 - $165.37 $24,678 - $29,766
-180 Reduced 10.47%
1,540 $247,000
Q2 2020

Jul 29, 2020

SELL
$111.92 - $142.53 $8,953 - $11,402
-80 Reduced 4.44%
1,720 $236,000
Q1 2020

May 12, 2020

SELL
$92.66 - $144.94 $185 - $289
-2 Reduced 0.11%
1,800 $212,000
Q4 2019

Feb 14, 2020

BUY
$116.25 - $133.25 $209,482 - $240,116
1,802 New
1,802 $238,000
Q3 2019

Nov 14, 2019

SELL
$112.57 - $128.43 $182,475 - $208,185
-1,621 Closed
0 $0
Q2 2019

Aug 06, 2019

SELL
$97.98 - $114.28 $13,227 - $15,427
-135 Reduced 7.69%
1,621 $163,000
Q1 2019

May 09, 2019

SELL
$81.56 - $100.67 $23,163 - $28,590
-284 Reduced 13.92%
1,756 $156,000
Q4 2018

Jan 25, 2019

BUY
$79.28 - $95.27 $5,391 - $6,478
68 Added 3.45%
2,040 $150,000
Q3 2018

Oct 23, 2018

BUY
$83.5 - $93.23 $25,718 - $28,714
308 Added 18.51%
1,972 $162,000
Q2 2018

Aug 10, 2018

BUY
$79.9 - $89.2 $4,474 - $4,995
56 Added 3.48%
1,664 $119,000
Q1 2018

May 10, 2018

BUY
$71.51 - $84.69 $9,296 - $11,009
130 Added 8.8%
1,608 $113,000
Q4 2017

Feb 14, 2018

BUY
$63.24 - $72.8 $93,468 - $107,598
1,478
1,478 $93,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $76.5B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Avestar Capital, LLC Portfolio

Follow Avestar Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avestar Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avestar Capital, LLC with notifications on news.